Medical Care
Global Insomnia Therapeutics Drugs Market Research Report 2025
- Sep 09, 25
- ID: 494474
- Pages: 77
- Figures: 71
- Views: 18
This report aims to provide a comprehensive presentation of the global market for Insomnia Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Therapeutics Drugs.
The Insomnia Therapeutics Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insomnia Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Segment by Type
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
Segment by Application
Prescription
Over-the-Counter (OTC)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Therapeutics Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Insomnia Therapeutics Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insomnia Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Segment by Type
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
Segment by Application
Prescription
Over-the-Counter (OTC)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Therapeutics Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Benzodiazepines
1.2.3 Nonbenzodiazepines
1.2.4 Antidepressants
1.2.5 Orexin Antagonists
1.2.6 Melatonin Antagonists
1.2.7 Others
1.3 Market by Application
1.3.1 Global Insomnia Therapeutics Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapeutics Drugs Market Perspective (2020-2031)
2.2 Global Insomnia Therapeutics Drugs Growth Trends by Region
2.2.1 Global Insomnia Therapeutics Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Insomnia Therapeutics Drugs Historic Market Size by Region (2020-2025)
2.2.3 Insomnia Therapeutics Drugs Forecasted Market Size by Region (2026-2031)
2.3 Insomnia Therapeutics Drugs Market Dynamics
2.3.1 Insomnia Therapeutics Drugs Industry Trends
2.3.2 Insomnia Therapeutics Drugs Market Drivers
2.3.3 Insomnia Therapeutics Drugs Market Challenges
2.3.4 Insomnia Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapeutics Drugs Players by Revenue
3.1.1 Global Top Insomnia Therapeutics Drugs Players by Revenue (2020-2025)
3.1.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Insomnia Therapeutics Drugs Revenue
3.4 Global Insomnia Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2024
3.5 Global Key Players of Insomnia Therapeutics Drugs Head office and Area Served
3.6 Global Key Players of Insomnia Therapeutics Drugs, Product and Application
3.7 Global Key Players of Insomnia Therapeutics Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapeutics Drugs Breakdown Data by Type
4.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2020-2025)
4.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2026-2031)
5 Insomnia Therapeutics Drugs Breakdown Data by Application
5.1 Global Insomnia Therapeutics Drugs Historic Market Size by Application (2020-2025)
5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Insomnia Therapeutics Drugs Market Size (2020-2031)
6.2 North America Insomnia Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Insomnia Therapeutics Drugs Market Size by Country (2020-2025)
6.4 North America Insomnia Therapeutics Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Therapeutics Drugs Market Size (2020-2031)
7.2 Europe Insomnia Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Insomnia Therapeutics Drugs Market Size by Country (2020-2025)
7.4 Europe Insomnia Therapeutics Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size (2020-2031)
8.2 Asia-Pacific Insomnia Therapeutics Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Therapeutics Drugs Market Size (2020-2031)
9.2 Latin America Insomnia Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Insomnia Therapeutics Drugs Market Size by Country (2020-2025)
9.4 Latin America Insomnia Therapeutics Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size (2020-2031)
10.2 Middle East & Africa Insomnia Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical Company Ltd.
11.1.1 Takeda Pharmaceutical Company Ltd. Company Details
11.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Introduction
11.1.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.1.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.2 Vanda Pharmaceuticals
11.2.1 Vanda Pharmaceuticals Company Details
11.2.2 Vanda Pharmaceuticals Business Overview
11.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Introduction
11.2.4 Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.2.5 Vanda Pharmaceuticals Recent Development
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Details
11.3.2 Merck & Co., Inc. Business Overview
11.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Introduction
11.3.4 Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.3.5 Merck & Co., Inc. Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.4.5 Pfizer Inc. Recent Development
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Company Details
11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Introduction
11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Details
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Insomnia Therapeutics Drugs Introduction
11.6.4 Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.6.5 Mylan N.V. Recent Development
11.7 Sumitomo Dainippon Pharma Co., Ltd
11.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
11.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Introduction
11.7.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Insomnia Therapeutics Drugs Introduction
11.8.4 Sanofi Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.8.5 Sanofi Recent Development
11.9 Paratek Pharmaceuticals Inc.
11.9.1 Paratek Pharmaceuticals Inc. Company Details
11.9.2 Paratek Pharmaceuticals Inc. Business Overview
11.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Introduction
11.9.4 Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.9.5 Paratek Pharmaceuticals Inc. Recent Development
11.10 Ebb Therapeutics
11.10.1 Ebb Therapeutics Company Details
11.10.2 Ebb Therapeutics Business Overview
11.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Introduction
11.10.4 Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.10.5 Ebb Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Benzodiazepines
1.2.3 Nonbenzodiazepines
1.2.4 Antidepressants
1.2.5 Orexin Antagonists
1.2.6 Melatonin Antagonists
1.2.7 Others
1.3 Market by Application
1.3.1 Global Insomnia Therapeutics Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapeutics Drugs Market Perspective (2020-2031)
2.2 Global Insomnia Therapeutics Drugs Growth Trends by Region
2.2.1 Global Insomnia Therapeutics Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Insomnia Therapeutics Drugs Historic Market Size by Region (2020-2025)
2.2.3 Insomnia Therapeutics Drugs Forecasted Market Size by Region (2026-2031)
2.3 Insomnia Therapeutics Drugs Market Dynamics
2.3.1 Insomnia Therapeutics Drugs Industry Trends
2.3.2 Insomnia Therapeutics Drugs Market Drivers
2.3.3 Insomnia Therapeutics Drugs Market Challenges
2.3.4 Insomnia Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapeutics Drugs Players by Revenue
3.1.1 Global Top Insomnia Therapeutics Drugs Players by Revenue (2020-2025)
3.1.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Insomnia Therapeutics Drugs Revenue
3.4 Global Insomnia Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2024
3.5 Global Key Players of Insomnia Therapeutics Drugs Head office and Area Served
3.6 Global Key Players of Insomnia Therapeutics Drugs, Product and Application
3.7 Global Key Players of Insomnia Therapeutics Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapeutics Drugs Breakdown Data by Type
4.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2020-2025)
4.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2026-2031)
5 Insomnia Therapeutics Drugs Breakdown Data by Application
5.1 Global Insomnia Therapeutics Drugs Historic Market Size by Application (2020-2025)
5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Insomnia Therapeutics Drugs Market Size (2020-2031)
6.2 North America Insomnia Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Insomnia Therapeutics Drugs Market Size by Country (2020-2025)
6.4 North America Insomnia Therapeutics Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Therapeutics Drugs Market Size (2020-2031)
7.2 Europe Insomnia Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Insomnia Therapeutics Drugs Market Size by Country (2020-2025)
7.4 Europe Insomnia Therapeutics Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size (2020-2031)
8.2 Asia-Pacific Insomnia Therapeutics Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Therapeutics Drugs Market Size (2020-2031)
9.2 Latin America Insomnia Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Insomnia Therapeutics Drugs Market Size by Country (2020-2025)
9.4 Latin America Insomnia Therapeutics Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size (2020-2031)
10.2 Middle East & Africa Insomnia Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical Company Ltd.
11.1.1 Takeda Pharmaceutical Company Ltd. Company Details
11.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Introduction
11.1.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.1.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.2 Vanda Pharmaceuticals
11.2.1 Vanda Pharmaceuticals Company Details
11.2.2 Vanda Pharmaceuticals Business Overview
11.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Introduction
11.2.4 Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.2.5 Vanda Pharmaceuticals Recent Development
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Details
11.3.2 Merck & Co., Inc. Business Overview
11.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Introduction
11.3.4 Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.3.5 Merck & Co., Inc. Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.4.5 Pfizer Inc. Recent Development
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Company Details
11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Introduction
11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Details
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Insomnia Therapeutics Drugs Introduction
11.6.4 Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.6.5 Mylan N.V. Recent Development
11.7 Sumitomo Dainippon Pharma Co., Ltd
11.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
11.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Introduction
11.7.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Insomnia Therapeutics Drugs Introduction
11.8.4 Sanofi Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.8.5 Sanofi Recent Development
11.9 Paratek Pharmaceuticals Inc.
11.9.1 Paratek Pharmaceuticals Inc. Company Details
11.9.2 Paratek Pharmaceuticals Inc. Business Overview
11.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Introduction
11.9.4 Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.9.5 Paratek Pharmaceuticals Inc. Recent Development
11.10 Ebb Therapeutics
11.10.1 Ebb Therapeutics Company Details
11.10.2 Ebb Therapeutics Business Overview
11.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Introduction
11.10.4 Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2020-2025)
11.10.5 Ebb Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Benzodiazepines
Table 3. Key Players of Nonbenzodiazepines
Table 4. Key Players of Antidepressants
Table 5. Key Players of Orexin Antagonists
Table 6. Key Players of Melatonin Antagonists
Table 7. Key Players of Others
Table 8. Global Insomnia Therapeutics Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Insomnia Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Insomnia Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Insomnia Therapeutics Drugs Market Share by Region (2020-2025)
Table 12. Global Insomnia Therapeutics Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Insomnia Therapeutics Drugs Market Share by Region (2026-2031)
Table 14. Insomnia Therapeutics Drugs Market Trends
Table 15. Insomnia Therapeutics Drugs Market Drivers
Table 16. Insomnia Therapeutics Drugs Market Challenges
Table 17. Insomnia Therapeutics Drugs Market Restraints
Table 18. Global Insomnia Therapeutics Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Insomnia Therapeutics Drugs Market Share by Players (2020-2025)
Table 20. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2024)
Table 21. Ranking of Global Top Insomnia Therapeutics Drugs Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Insomnia Therapeutics Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Insomnia Therapeutics Drugs, Headquarters and Area Served
Table 24. Global Key Players of Insomnia Therapeutics Drugs, Product and Application
Table 25. Global Key Players of Insomnia Therapeutics Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Insomnia Therapeutics Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2020-2025)
Table 29. Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2026-2031)
Table 31. Global Insomnia Therapeutics Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2020-2025)
Table 33. Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2026-2031)
Table 35. North America Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Insomnia Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Insomnia Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Insomnia Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Insomnia Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Insomnia Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Insomnia Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Insomnia Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 50. Takeda Pharmaceutical Company Ltd. Company Details
Table 51. Takeda Pharmaceutical Company Ltd. Business Overview
Table 52. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product
Table 53. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 54. Takeda Pharmaceutical Company Ltd. Recent Development
Table 55. Vanda Pharmaceuticals Company Details
Table 56. Vanda Pharmaceuticals Business Overview
Table 57. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product
Table 58. Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 59. Vanda Pharmaceuticals Recent Development
Table 60. Merck & Co., Inc. Company Details
Table 61. Merck & Co., Inc. Business Overview
Table 62. Merck & Co., Inc. Insomnia Therapeutics Drugs Product
Table 63. Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 64. Merck & Co., Inc. Recent Development
Table 65. Pfizer Inc. Company Details
Table 66. Pfizer Inc. Business Overview
Table 67. Pfizer Inc. Insomnia Therapeutics Drugs Product
Table 68. Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 69. Pfizer Inc. Recent Development
Table 70. Teva Pharmaceutical Industries Ltd. Company Details
Table 71. Teva Pharmaceutical Industries Ltd. Business Overview
Table 72. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product
Table 73. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 74. Teva Pharmaceutical Industries Ltd. Recent Development
Table 75. Mylan N.V. Company Details
Table 76. Mylan N.V. Business Overview
Table 77. Mylan N.V. Insomnia Therapeutics Drugs Product
Table 78. Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 79. Mylan N.V. Recent Development
Table 80. Sumitomo Dainippon Pharma Co., Ltd Company Details
Table 81. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 82. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product
Table 83. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 84. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Insomnia Therapeutics Drugs Product
Table 88. Sanofi Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Paratek Pharmaceuticals Inc. Company Details
Table 91. Paratek Pharmaceuticals Inc. Business Overview
Table 92. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product
Table 93. Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 94. Paratek Pharmaceuticals Inc. Recent Development
Table 95. Ebb Therapeutics Company Details
Table 96. Ebb Therapeutics Business Overview
Table 97. Ebb Therapeutics Insomnia Therapeutics Drugs Product
Table 98. Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 99. Ebb Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Insomnia Therapeutics Drugs Picture
Figure 2. Global Insomnia Therapeutics Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Insomnia Therapeutics Drugs Market Share by Type: 2024 VS 2031
Figure 4. Benzodiazepines Features
Figure 5. Nonbenzodiazepines Features
Figure 6. Antidepressants Features
Figure 7. Orexin Antagonists Features
Figure 8. Melatonin Antagonists Features
Figure 9. Others Features
Figure 10. Global Insomnia Therapeutics Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Insomnia Therapeutics Drugs Market Share by Application: 2024 VS 2031
Figure 12. Prescription Case Studies
Figure 13. Over-the-Counter (OTC) Case Studies
Figure 14. Insomnia Therapeutics Drugs Report Years Considered
Figure 15. Global Insomnia Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Insomnia Therapeutics Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Insomnia Therapeutics Drugs Market Share by Region: 2024 VS 2031
Figure 18. Global Insomnia Therapeutics Drugs Market Share by Players in 2024
Figure 19. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Insomnia Therapeutics Drugs Revenue in 2024
Figure 21. North America Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Insomnia Therapeutics Drugs Market Share by Country (2020-2031)
Figure 23. United States Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Insomnia Therapeutics Drugs Market Share by Country (2020-2031)
Figure 27. Germany Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Insomnia Therapeutics Drugs Market Share by Region (2020-2031)
Figure 35. China Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Insomnia Therapeutics Drugs Market Share by Country (2020-2031)
Figure 43. Mexico Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Insomnia Therapeutics Drugs Market Share by Country (2020-2031)
Figure 47. Turkey Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 51. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 52. Merck & Co., Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 53. Pfizer Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 54. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 55. Mylan N.V. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 56. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 57. Sanofi Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 58. Paratek Pharmaceuticals Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 59. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Benzodiazepines
Table 3. Key Players of Nonbenzodiazepines
Table 4. Key Players of Antidepressants
Table 5. Key Players of Orexin Antagonists
Table 6. Key Players of Melatonin Antagonists
Table 7. Key Players of Others
Table 8. Global Insomnia Therapeutics Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Insomnia Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Insomnia Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Insomnia Therapeutics Drugs Market Share by Region (2020-2025)
Table 12. Global Insomnia Therapeutics Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Insomnia Therapeutics Drugs Market Share by Region (2026-2031)
Table 14. Insomnia Therapeutics Drugs Market Trends
Table 15. Insomnia Therapeutics Drugs Market Drivers
Table 16. Insomnia Therapeutics Drugs Market Challenges
Table 17. Insomnia Therapeutics Drugs Market Restraints
Table 18. Global Insomnia Therapeutics Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Insomnia Therapeutics Drugs Market Share by Players (2020-2025)
Table 20. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2024)
Table 21. Ranking of Global Top Insomnia Therapeutics Drugs Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Insomnia Therapeutics Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Insomnia Therapeutics Drugs, Headquarters and Area Served
Table 24. Global Key Players of Insomnia Therapeutics Drugs, Product and Application
Table 25. Global Key Players of Insomnia Therapeutics Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Insomnia Therapeutics Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2020-2025)
Table 29. Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2026-2031)
Table 31. Global Insomnia Therapeutics Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2020-2025)
Table 33. Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2026-2031)
Table 35. North America Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Insomnia Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Insomnia Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Insomnia Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Insomnia Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Insomnia Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Insomnia Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Insomnia Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 50. Takeda Pharmaceutical Company Ltd. Company Details
Table 51. Takeda Pharmaceutical Company Ltd. Business Overview
Table 52. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product
Table 53. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 54. Takeda Pharmaceutical Company Ltd. Recent Development
Table 55. Vanda Pharmaceuticals Company Details
Table 56. Vanda Pharmaceuticals Business Overview
Table 57. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product
Table 58. Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 59. Vanda Pharmaceuticals Recent Development
Table 60. Merck & Co., Inc. Company Details
Table 61. Merck & Co., Inc. Business Overview
Table 62. Merck & Co., Inc. Insomnia Therapeutics Drugs Product
Table 63. Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 64. Merck & Co., Inc. Recent Development
Table 65. Pfizer Inc. Company Details
Table 66. Pfizer Inc. Business Overview
Table 67. Pfizer Inc. Insomnia Therapeutics Drugs Product
Table 68. Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 69. Pfizer Inc. Recent Development
Table 70. Teva Pharmaceutical Industries Ltd. Company Details
Table 71. Teva Pharmaceutical Industries Ltd. Business Overview
Table 72. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product
Table 73. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 74. Teva Pharmaceutical Industries Ltd. Recent Development
Table 75. Mylan N.V. Company Details
Table 76. Mylan N.V. Business Overview
Table 77. Mylan N.V. Insomnia Therapeutics Drugs Product
Table 78. Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 79. Mylan N.V. Recent Development
Table 80. Sumitomo Dainippon Pharma Co., Ltd Company Details
Table 81. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 82. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product
Table 83. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 84. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Insomnia Therapeutics Drugs Product
Table 88. Sanofi Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Paratek Pharmaceuticals Inc. Company Details
Table 91. Paratek Pharmaceuticals Inc. Business Overview
Table 92. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product
Table 93. Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 94. Paratek Pharmaceuticals Inc. Recent Development
Table 95. Ebb Therapeutics Company Details
Table 96. Ebb Therapeutics Business Overview
Table 97. Ebb Therapeutics Insomnia Therapeutics Drugs Product
Table 98. Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 99. Ebb Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Insomnia Therapeutics Drugs Picture
Figure 2. Global Insomnia Therapeutics Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Insomnia Therapeutics Drugs Market Share by Type: 2024 VS 2031
Figure 4. Benzodiazepines Features
Figure 5. Nonbenzodiazepines Features
Figure 6. Antidepressants Features
Figure 7. Orexin Antagonists Features
Figure 8. Melatonin Antagonists Features
Figure 9. Others Features
Figure 10. Global Insomnia Therapeutics Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Insomnia Therapeutics Drugs Market Share by Application: 2024 VS 2031
Figure 12. Prescription Case Studies
Figure 13. Over-the-Counter (OTC) Case Studies
Figure 14. Insomnia Therapeutics Drugs Report Years Considered
Figure 15. Global Insomnia Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Insomnia Therapeutics Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Insomnia Therapeutics Drugs Market Share by Region: 2024 VS 2031
Figure 18. Global Insomnia Therapeutics Drugs Market Share by Players in 2024
Figure 19. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Insomnia Therapeutics Drugs Revenue in 2024
Figure 21. North America Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Insomnia Therapeutics Drugs Market Share by Country (2020-2031)
Figure 23. United States Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Insomnia Therapeutics Drugs Market Share by Country (2020-2031)
Figure 27. Germany Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Insomnia Therapeutics Drugs Market Share by Region (2020-2031)
Figure 35. China Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Insomnia Therapeutics Drugs Market Share by Country (2020-2031)
Figure 43. Mexico Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Insomnia Therapeutics Drugs Market Share by Country (2020-2031)
Figure 47. Turkey Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Insomnia Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 51. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 52. Merck & Co., Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 53. Pfizer Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 54. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 55. Mylan N.V. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 56. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 57. Sanofi Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 58. Paratek Pharmaceuticals Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 59. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232